(Q33497848)

27 July 2017

Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor (English)

1 reference

27 July 2017

1 reference

1 reference

Bernd Walter Scheithauer

10

object named as

Scheithauer BW

1 reference

27 July 2017

Cascino TL

1

1 reference

27 July 2017

Veeder MH

2

1 reference

27 July 2017

Buckner JC

3

1 reference

27 July 2017

O'Fallon JR

4

1 reference

27 July 2017

Wiesenfeld M

5

1 reference

27 July 2017

Levitt R

6

1 reference

27 July 2017

Goldberg RM

7

1 reference

27 July 2017

Kuross SA

8

1 reference

27 July 2017

Morton RF

9

1 reference

27 July 2017

language of work or name

1 reference

1 December 1996

1 reference

Journal of Neuro-Oncology

27 July 2017

1 reference

27 July 2017

30

1 reference

27 July 2017

3

1 reference

27 July 2017

243-246

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00177275

27 July 2017

0 references

cites work

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

12 December 2020

A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma

1 reference

12 December 2020

Treatment of recurrent brain stem gliomas and other central nervous system tumors with 5-fluorouracil, CCNU, hydroxyurea, and 6-mercaptopurine

1 reference

12 December 2020

Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomas.

1 reference

12 December 2020

Glioblastoma multiforme. An analysis of the results of postoperative radiotherapy alone versus radiotherapy and concomitant 5-fluorouracil. (A prospective randomized study of 32 cases)

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00177275

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference